CWM
TVTX icon

CIBC World Markets’s Travere Therapeutics TVTX Stock Holding History

CIBC World Markets’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$209K Buy
+5,458
New +$177K ﹤0.01% 1110
2025
Q2 		$161K Sell
10,863
-7,803
-42% -$129K ﹤0.01% 1322
2025
Q1 		$334K Buy
+18,666
New +$379K ﹤0.01% 1206

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CIBC World Markets's TVTX Position: Q4 2025 in Review

CIBC World Markets opened a new position in Travere Therapeutics (TVTX) in Q4 2025: 5,458 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #1110 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in TVTX as recently as Q2 2025.

CIBC World Markets first reported a position in TVTX in Q1 2025 and has held it in 3 quarters since. The position peaked at $334K in Q1 2025. 278 funds tracked by Wall St. Rank hold TVTX as of Q4 2025.

  • CIBC World Markets held 5,458 shares of Travere Therapeutics worth $209K as of Q4 2025.
  • Travere Therapeutics was a new CIBC World Markets position in Q4 2025.
  • Travere Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1110 holding.
  • CIBC World Markets first reported a position in Travere Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • CIBC World Markets's Travere Therapeutics position peaked at $334K in Q1 2025.
  • 278 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.